Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.medcli.2021.01.004 http://scihub22266oqcxt.onion/10.1016/j.medcli.2021.01.004 33632511!7843069!33632511     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33632511&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Med+Clin+(Barc) 2021 ; 157 (3): 114-117 Nephropedia Template TP {{tp|p=33632511|t=2021. Infeccion por SARS-CoV-2: un factor predisponente para sindrome coronario agudo |pdf=|usr=}}{{33632511}} gab.com Text Infeccion por SARS-CoV-2: un factor predisponente para sindrome coronario agudo JO: Med Clin (Barc) http://www.kidney.de/pget.php?&tw=1&pmid=33632511 #FOAvip INTRODUCTION: Several case series of ACS have been reported in COVID 19 patients. We aim to study its incidence, characteristics, and three-month prognosis. To put this incidence in perspective we compared it with the incidence of in-hospital ACS during the same period of 2019. METHODS: Observational multicenter cohort study of 3,108 COVID-19 patients admitted to two hospitals in Madrid between March 1st and May 15th, 2020. Ten patients suffered an ACS while being hospitalized for COVID 19 and were followed for three months. The ACS incidence in hospitalized patients during the same period of 2019 was also studied. RESULTS: The incidence of ACS in COVID-19 patients was 3.31 per thousand, significantly higher than in the 2019 period, 1.01 per thousand (p = 0.013). COVID-19 patients that suffered and ACS frequently had a severe infection, presented with STEMI (80%), and had multivessel disease (67%). Mortality rate (30%) and hospital readmissions at three months (20%) were very high. CONCLUSIONS: Severe COVID-19 patients develop ACS more frequently than expected. Although the overall incidence was low, it carried a poor immediate and three-month prognosis. Twit Text FOAVip Infeccion por SARS-CoV-2: un factor predisponente para sindrome coronario agudo ????Med Clin (Barc) http://www.kidney.de/pget.php?&tw=1&pmid=33632511 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33632511 #FOAvip English Wikipedia <ref>{{Cite pmid|33632511}}</ref> Infeccion por SARS-CoV-2: un factor predisponente para sindrome coronario agudo #MMPMID33632511 de Cortina Camarero C; Gomez Mariscal E; Espejo Bares V; Nunez Garcia A; Munoz Aguilera R; Botas Rodriguez J Med Clin (Barc) 2021[Aug]; 157 (3): 114-117 PMID33632511show ga INTRODUCTION: Several case series of ACS have been reported in COVID 19 patients. We aim to study its incidence, characteristics, and three-month prognosis. To put this incidence in perspective we compared it with the incidence of in-hospital ACS during the same period of 2019. METHODS: Observational multicenter cohort study of 3,108 COVID-19 patients admitted to two hospitals in Madrid between March 1st and May 15th, 2020. Ten patients suffered an ACS while being hospitalized for COVID 19 and were followed for three months. The ACS incidence in hospitalized patients during the same period of 2019 was also studied. RESULTS: The incidence of ACS in COVID-19 patients was 3.31 per thousand, significantly higher than in the 2019 period, 1.01 per thousand (p = 0.013). COVID-19 patients that suffered and ACS frequently had a severe infection, presented with STEMI (80%), and had multivessel disease (67%). Mortality rate (30%) and hospital readmissions at three months (20%) were very high. CONCLUSIONS: Severe COVID-19 patients develop ACS more frequently than expected. Although the overall incidence was low, it carried a poor immediate and three-month prognosis. |*Acute Coronary Syndrome/diagnosis/epidemiology[MESH] |*COVID-19[MESH] |Causality[MESH] |Cohort Studies[MESH] |Hospitalization[MESH]Infeccion por SARS-CoV-2: un factor predisponente para sindrome corona(epmc).pdf DeepDyve Pubget Overpricing